抗凝治疗期间的特发性血栓栓塞复发。

Japanese circulation journal Pub Date : 2001-07-20 DOI:10.1253/JCJ.65.755

K. Tanimoto, K. Mizushige, K. Yukiiri, T. Ueda, W. Yoshihiro, K. Ohmori, M. Kohno

{"title":"抗凝治疗期间的特发性血栓栓塞复发。","authors":"K. Tanimoto, K. Mizushige, K. Yukiiri, T. Ueda, W. Yoshihiro, K. Ohmori, M. Kohno","doi":"10.1253/JCJ.65.755","DOIUrl":null,"url":null,"abstract":"Patients with acute pulmonary embolism and venous thromboembolism are usually treated with anticoagulant therapy for at least 3 months as the optimum duration. A patient with recurrent idiopathic venous thromboembolism at the eighth month during anticoagulation (warfarin to target international normalized ratio of 2.0-3.0) is described. The case suggests that patients with idiopathic venous thromboembolism have a high risk of recurrence, even if a strict anticoagulant regimen is followed.","PeriodicalId":14544,"journal":{"name":"Japanese circulation journal","volume":"28 8","pages":"755-6"},"PeriodicalIF":0.0000,"publicationDate":"2001-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Recurrence of idiopathic thromboembolism during anticoagulant therapy.\",\"authors\":\"K. Tanimoto, K. Mizushige, K. Yukiiri, T. Ueda, W. Yoshihiro, K. Ohmori, M. Kohno\",\"doi\":\"10.1253/JCJ.65.755\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Patients with acute pulmonary embolism and venous thromboembolism are usually treated with anticoagulant therapy for at least 3 months as the optimum duration. A patient with recurrent idiopathic venous thromboembolism at the eighth month during anticoagulation (warfarin to target international normalized ratio of 2.0-3.0) is described. The case suggests that patients with idiopathic venous thromboembolism have a high risk of recurrence, even if a strict anticoagulant regimen is followed.\",\"PeriodicalId\":14544,\"journal\":{\"name\":\"Japanese circulation journal\",\"volume\":\"28 8\",\"pages\":\"755-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2001-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese circulation journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1253/JCJ.65.755\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese circulation journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1253/JCJ.65.755","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 4

摘要

急性肺栓塞和静脉血栓栓塞患者通常以抗凝治疗至少3个月为最佳疗程。本文报道一例在抗凝治疗第8个月时复发的特发性静脉血栓栓塞患者(华法林与目标的国际标准化比值为2.0-3.0)。该病例提示，特发性静脉血栓栓塞患者有很高的复发风险，即使遵循严格的抗凝治疗方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Recurrence of idiopathic thromboembolism during anticoagulant therapy.

Patients with acute pulmonary embolism and venous thromboembolism are usually treated with anticoagulant therapy for at least 3 months as the optimum duration. A patient with recurrent idiopathic venous thromboembolism at the eighth month during anticoagulation (warfarin to target international normalized ratio of 2.0-3.0) is described. The case suggests that patients with idiopathic venous thromboembolism have a high risk of recurrence, even if a strict anticoagulant regimen is followed.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Japanese circulation journal

自引率

0.00%

发文量